The store will not work correctly when cookies are disabled.
5-((4R,5R)-5-(4-fluorophenyl)-4-methyl-2-oxooxazolidin-3-yl)isophthalonitrile
ID: ALA5278664
Max Phase: Preclinical
Molecular Formula: C18H12FN3O2
Molecular Weight: 321.31
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@@H]1[C@@H](c2ccc(F)cc2)OC(=O)N1c1cc(C#N)cc(C#N)c1
Standard InChI: InChI=1S/C18H12FN3O2/c1-11-17(14-2-4-15(19)5-3-14)24-18(23)22(11)16-7-12(9-20)6-13(8-16)10-21/h2-8,11,17H,1H3/t11-,17+/m1/s1
Standard InChI Key: NJAIJURIMBUHLD-DIFFPNOSSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-2.6807 -0.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0929 0.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6810 0.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8556 0.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4438 0.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8519 -0.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6184 0.0031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1336 0.6705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6508 0.4155 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6508 -0.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1336 -0.6641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3652 -0.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0797 -0.4094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7915 -0.8212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7915 -1.6463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0816 -2.0581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3652 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0930 -1.4276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0934 1.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5058 2.1420 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5055 -2.1420 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3471 1.4672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3471 -1.4609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5058 -2.0588 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
7 5 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 7 1 0
10 11 1 0
10 12 1 6
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
1 18 1 0
3 19 1 0
19 20 3 0
18 21 3 0
8 22 2 0
11 23 1 1
15 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.31 | Molecular Weight (Monoisotopic): 321.0914 | AlogP: 3.66 | #Rotatable Bonds: 2 |
Polar Surface Area: 77.12 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.58 | CX LogD: 3.58 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -0.38 |
References
1. Fernandes GFS, Scarim CB, Kim SH, Wu J, Castagnolo D.. (2023) Oxazolidinones as versatile scaffolds in medicinal chemistry., 14 (5): [PMID:37252095] [10.1039/d2md00415a] |